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Accumulating evidence suggests that neuregulin 1 (NRG1) might be involved in the
neurodevelopment, neural plasticity, GABAergic neurotransmission, and pathogenesis
of schizophrenia. NRG1 is abundantly expressed in the hippocampus, and emerging
studies have begun to reveal the link between NRG1 signaling and cognitive deficits
in schizophrenic patients. Because the transmembrane domain of NRG1 is vital for
both forward and reverse signaling cascades, new Nrg1-deficient mice that carry a
truncation of the transmembrane domain of the Nrg1 gene were characterized and
used in this study to test a NRG1 loss-of-function hypothesis for schizophrenia. Both
male and female Nrg1 heterozygous mutant mice and their wild-type littermates were
used in a series of 4 experiments to characterize the impact of Nrg1 on behavioral
phenotypes and to determine the importance of Nrg1 in the regulation of hippocampal
neuromorphology and local GABAergic interneurons. First, a comprehensive battery of
behavioral tasks indicated that male Nrg1-deficient mice exhibited significant impairments
in cognitive functions. Second, pharmacological challenges were conducted and revealed
that Nrg1 haploinsufficiency altered GABAergic activity in males. Third, although no
genotype-specific neuromorphological alterations were found in the hippocampal CA1
pyramidal neurons, significant reductions in the hippocampal expressions of GAD67 and
parvalbumin were revealed in the Nrg1-deficient males. Fourth, chronic treatment with
valproate rescued the observed behavioral deficits and hippocampal GAD67 reduction in
Nrg1-deficient males. Collectively, these results indicate the potential therapeutic effect
of valproate and the importance of Nrg1 in the regulation of cognitive functions and
hippocampal GABAergic interneurons, especially in males.
Keywords: schizophrenia, transmembrane-domain Nrg1 mutant mice, cognitive function, hippocampus,
GABAergic interneuron, valproate
INTRODUCTION
Schizophrenia is a costly and devastating mental disorder that
afflicts∼1% of the worldwide population (Insel, 2010). It appears
to be a multifactorial disorder with a strong genetic predisposi-
tion. Accumulating evidence from human genetic studies suggests
that multiple susceptibility genes or loci, including Neuregulin
1 (NRG1) (Schwab and Wildenauer, 2009), might contribute
to the pathogenesis of schizophrenia. The association between
NRG1 and schizophrenia was initially revealed in a study of
families in Iceland (Stefansson et al., 2002), and the associa-
tion has been further confirmed in other ethnic groups (Walker
et al., 2010). Reduced levels of the expression of NRG1 have also
been reported in schizophrenic post-mortem tissues (Bertram
et al., 2007; Nicodemus et al., 2009; Parlapani et al., 2010),
which indicates that alterations in NRG1 might contribute to the
pathophysiology of schizophrenia.
NRG1, a trophic factor, belongs to the neuregulin family of
growth factors, whose effects are mediated via four neuregulin
genes (NRG1-4) that bind to the ErbB (epidermal growth factor-
like receptor) family of tyrosine kinase transmembrane receptors
(ErbB1-4) (Harrison and Weinberger, 2005; O’Tuathaigh et al.,
2006). As a consequence of multiple promoters and rich alter-
native splicing, more than 30 different NRG1 isoforms produced
from a single NRG1 gene have been identified to date, and these
isoforms have been classified into at least 7 different isoform types
(Falls, 2003; Steinthorsdottir et al., 2004; Walss-Bass et al., 2006;
Mei and Xiong, 2008). Pro-Neuregulin 1, which contains a trans-
membrane domain (i.e., the TMc domain, a critical motif for
forward and reverse signaling cascades) that forms membrane-
anchored precursors, undergoes proteolytic cleavage leading to
mature NRG1. NRG1, as a ligand and a receptor for ErbB3 and
ErbB4, initiates forward or reverse signaling pathways that have
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numerous neurotrophic roles (Liu et al., 1998a,b; Bao et al., 2003;
Falls, 2003), and NRG1 is abundant in many brain regions, espe-
cially in the hippocampus (Law et al., 2004). Numerous roles for
NRG1 in CNS development and function have been identified,
including synapse formation, neuronal migration, axon guid-
ance, axon myelination, synaptic plasticity, and the regulation of
neurotransmitter expression (Harrison and Law, 2006; Mei and
Xiong, 2008; Iwakura and Nawa, 2013). The abundant expres-
sions of NRG1 and ErbB and the interactions of these molecules
with GABAergic (Yau et al., 2003; Vullhorst et al., 2009; Neddens
and Buonanno, 2010), glutamatergic (Hahn et al., 2006; Li et al.,
2007), and dopaminergic neurons (Abe et al., 2009; Kato et al.,
2011) imply that these molecules have critical roles in the regu-
lation of synaptic plasticity at excitatory and inhibitory synapses
that might be involved in the pathogenesis of the cognitive deficits
in schizophrenia. Indeed, a novel missense mutation (Val to Leu)
in the TMc domain of NRG1 was reported to be associated with
schizophrenia (Walss-Bass et al., 2006), suggesting a potential
causal mutations within this gene.
Evidence revealing the link between Nrg1/ErbB4 and cognitive
deficits in patients with schizophrenia has begun to accumulate
(Hall et al., 2006; Krug et al., 2010). A number of Nrg1-related
mutant mice have been generated to further elucidate the role
of Nrg1 in the pathogenesis of schizophrenia-related behavioral
and cognitive deficits (O’Tuathaigh et al., 2007; Chen et al., 2008;
Ehrlichman et al., 2009; Duffy et al., 2010; Wen et al., 2010;
Shamir et al., 2012). For example, Nrg1 heterozygous knock-
out mice with TMc-domain truncation of exon 11 were first
reported in 2002 (Stefansson et al., 2002) and this original TMc-
Nrg1+/− mutant strain has been reported to exhibit behavioral
deficits in locomotor activity, explorative behavior, and anxiety-
like behaviors (O’Tuathaigh et al., 2006; Boucher et al., 2007).
Age-dependent alterations in locomotor activity and exploratory
behavior have also been reported in these original TMc-Nrg1+/−
mutant mice (Karl et al., 2007). Alterations in social and cognitive
function have also been reported in these TMc-Nrg1+/− mutant
mice, such as increased aggression, increased social recogni-
tion, decreased prepulse inhibition, and impaired contextual fear
conditioning (Stefansson et al., 2002; O’Tuathaigh et al., 2007;
Chesworth et al., 2012; Desbonnet et al., 2012). Furthermore,
the involvement of Nrg1 in the modulation of cognitive func-
tions has been further bolstered by in vitro electrophysiological
studies in the hippocampus of EGF-like domain Nrg1+/− mice
(Bjarnadottir et al., 2007). A recent study also indicated that
ErbB4-null parvalbumin interneuron-restricted mutant mice and
EGF-like domain Nrg1+/− mice exhibit increased hippocampal
LTP (Shamir et al., 2012). These studies suggest the impor-
tance of Nrg1 in the regulation of basic behavioral functions
and hippocampal electrophysiology, which might account for the
alterations of cognitive functions in these mice. Although some
interesting findings were reported, these previous behavioral
phenotyping results appear to be somewhat inconsistent across
these Nrg1-related mutant mice or even across variants of some
lines of Nrg1 mutant mice from one study to another. It is
also difficult to make direct comparisons between different lines
of mutant mice because different gene targeting strategies were
used in different studies and because the expression levels of
Nrg1 protein in these haploinsufficient mice are not available
due to the lack of antibodies that are capable of recogniz-
ing the different isoforms. Besides, in the past decade, most of
Nrg1-related mouse studies were conducted in male mice and
only a few studies used either female mice or both male and
female mice. Interestingly, sex-specific effects were reported. For
example, using both male and female TMc-Nrg1+/− mutant
mice, it was previously found that only male mutant mice had
impaired performance in Barnes maze (O’Tuathaigh et al., 2007)
and only female mutant mice had reduced grooming behavior
(O’Tuathaigh et al., 2006). It is of interest to further compare
sex-specific effect on different behavioral tasks in Nrg1-related
mutant mice.
To further characterize the effects of Nrg1 haploinsufficiency
and to validate the impact of the complete truncation of the
Nrg1 TMc-domain on cognitive functioning and its behavioral
consequences in both males and females, a novel line of TMc-
domainNrg1+/− mutant mice with a truncation from exon 9 was
obtained and used in this study. A set of four experiments was
designed. Because sex (or sex hormones) might have differential
effects onNRG/ErbB via glial-neuronal signaling in schizophrenic
patients (Lacroix-Fralish et al., 2006; Wong and Weickert, 2009)
and because sex-specific effects of Nrg1 on behavioral pheno-
types have not been well characterized in mice, both male and
female mice were used in Experiments 1–3. In Experiment 1,
a comprehensive battery of cognitive-related tasks (Experiment
1A) and basic behavioral tasks (Experiment 1B) was applied to
evaluate the behavioral phenotype of the novel TMc-Nrg1+/−
mutant mice. Experiments 2 and 3 were conducted to facil-
itate the interpretation of the behavioral deficits observed in
Experiment 1. Accordingly, in Experiment 2, MK-801 (an NMDA
receptor antagonist), methamphetamine (a potent psychostimu-
lant that increases the amount of extracellular dopamine), and
pentylenetetrazol (PTZ, a GABAA receptor antagonist) were used
to induce behavioral alterations and to reveal which neuro-
transmitters were more vulnerable in these novel TMc-Nrg1+/−
mutant mice. Neuromorphological and neurochemical alter-
ations in the hippocampi of these mutant mice were further
examined in Experiments 3A and 3B, respectively. Based on the
findings from the first 3 experiments, an effective and useful pro-
cedure of valproate (a GABA transaminase inhibitor) treatment
(Guidotti et al., 2009) was used to evaluate whether rescue of the
observed cognitive deficits in these novel TMc-Nrg1+/− mice was
possible.
MATERIALS AND METHODS
ANIMALS
All neuregulin 1 heterozygous mutant mice (Nrg1+/−) and
wild-type (WT) littermate mice used in this study were gen-
erated from Nrg1+/− breeding pairs with C57BL/6J genetic
backgrounds (n > 10). Only Nrg1+/− mice were used because
Nrg1 homozygous embryos die due to cardiac defects around
E10.5–E11.5 (Gassmann et al., 1995; Meyer and Birchmeier, 1995;
Kramer et al., 1996). Nrg1+/− mice were healthy, and basic phys-
ical examination revealed no observable physical damage. Mice
were weaned at 4 weeks and separated by sex. Littermates of
the same sex were caged separately and maintained in groups
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of 3–5 mice per cage. For behavioral testing, each mouse was
housed individually 1 week before behavioral testing. All mice
were housed, with food and water provided ad libitum, in indi-
vidually ventilated polysulfone cages (Alternative design Inc.,
U.S.A.) within the animal rooms of the Psychology Department
of National Taiwan University. All animals used in this study
were adult mice (at least 2 months of age). They were handled
and weighed daily for at least 1 week prior to each exper-
iment. All behavioral and pharmacological experiments were
conducted in the dark phase. Minimal numbers of mice were
used to meet the 3R reduction principle of animal use. All ani-
mal procedures were performed according to protocols approved
by the Animal Care and Use Committee of National Taiwan
University. Adequate measures were taken to minimize potential
pain and discomfort that the mice used in this study may have
experienced.
OBTAINMENT AND VALIDATION OF THE NOVEL TMc-Nrg1+/− MICE
Given the fact that the TMc domain of NRG1 is a critical motif for
NRG1 forward and reverse signaling cascades and that reduced
levels of the expression of NRG1 have been reported in some
schizophrenic post-mortem tissues, the validation of this novel
TMc-Nrg1 mutant mouse strain is important and this mouse
strain is beneficial to study the effect of TMc domain of Nrg1
in the pathogenesis of schizophrenia-related symptoms. In com-
plementary to other Nrg1-related mouse strains, this novel strain
of mice is also helpful to elucidate the functional consequences
of TMc domain ablation and the impact of Nrg1 TMc-domain
complete truncation on behavioral functions. The novel TMc-
Nrg1 mutant mice were originally generated by Lexicon Genetics
(NIH-0932, LEXKO-1007) using pKOS-53 with LacZ/Neo cas-
settes. Using homologous recombination, exon 9 ofNrg1,where it
was translated into the TMc domain, were targeted and truncated
by the LacZ/Neo cassettes. Further information about this mouse
has been described previously (http://www.informatics.jax.org/
external/ko/lexicon/4608.html). A schematic diagram of the tar-
geting strategy is depicted in Figure 1A. The entire sequence
encoding the TMc is encoded by a single exon so that the trun-
cated exon can be referred as the TMc exon. Likely due to
differences in exon annotations, the targeted TMc exon was pre-
viously referred to as exon 11 in the original TMc-Nrg1 mutant
strain (Stefansson et al., 2002) and it was referred to as exon 9
in our novel TMc-Nrg1 mutant strain here. The expected sizes
of the PCR products for the novel TMc-Nrg1 mice are indi-
cated in Figure 1A as well. Genomic DNA isolated from the tails
of the mice of the indicated genotypes was submitted to PCR,
and WT and recombinant alleles were distinguished with agarose
gel electrophoresis (Figure 1B). The following primers were used
to confirm the genotypes of the mice: 0932-8, 5′-GTCATGAAG
CATGCCAGCTG-3′; 0932-10, 5′-GTATTACTCAGTCGGGAAC-
3′; and Neo3a, 5′-GCAGCGCATCGCCTTCTATC-3′ (Figure 1).
The TMc domain of Nrg1 was truncated by the target vector,
which resulted in the lack of a C-terminal on Nrg1 and a resis-
tance to proteolytic release. The deletion included the sequence
VLTITGICIALLVVGIMCVVAY, which has been described previ-
ously as the TMc domain of Nrg1 (Walss-Bass et al., 2006). The
truncated region starts with a hydrophilic part and the majority
in this region appears to be hydrophobic (average hydrophobic-
ity = 1.233; >1 means this region is hydrophobic) based on
analyses with SOSUI (i.e., a classification and secondary struc-
ture prediction system for membrane proteins) (Hirokawa et al.,
1998). The result of hydrophobicity analysis predicts that this
region is in the very 5′ region of the TMc-domain of Nrg1 and it is
translated as a hydrophobic protein structure because most of the
amino acids in the TMc-domain are hydrophobic. The expres-
sion of Nrg1 protein in the cerebral cortex of the novel TMc-
Nrg1+/−mutant mice was further validated using Western blot
with a Nrg1 C-terminal antibody (Neuregulin-1α/β1/2, 1:500,
sc348, Santa Cruz Biotechnology). As indicated in Figure 1C,
compared toWT littermate controls, a significant (∼37%) reduc-
tion of Nrg1 protein (∼51 kDa) was found in the brains of the
novel TMc-Nrg1+/− mice [WT: 1 ± 0.013; Nrg1+/−: 0.628 ±
0.110; t(4) = 3.373; p = 0.027].
EXPERIMENT 1: EXAMINATION OF THE COGNITIVE AND BASIC
BEHAVIORAL FUNCTIONING OF THE NOVEL TMc-Nrg1+/−
MUTANT MICE
Two cohorts of male and female adult TMc-Nrg1+/− mice
and their WT littermates were used in this experiment. Two
series of experiments were conducted to examine the effects of
Nrg1 haploinsufficiency on the cognitive functions (Experiment
1A) and the basic behaviors (Experiment 1B) in these mice.
Cognitive function-related behavioral tasks used in this experi-
ment included the object recognition task, contextual and cued
fear conditioning, the Morris water maze task, prepulse inhi-
bition, and social preference and recognition task. The object
recognition task, contextual fear conditioning, Morris water
maze, and social recognition task are considered to be related
to hippocampus-dependent function. Cued fear conditioning is
considered to rely heavily upon the amygdala. Prepulse inhibi-
tion was performed to measure sensorimotor gating function in
these mice. Basic behaviors (Experiment 1B) were evaluated with
a battery of behavioral tasks that consisted of an open-field loco-
motor assay, a hole board task, an elevated plus maze task, a
sucrose preference task, and a hot plate task. Because it has been
reported that some basic behaviors might be age-dependent in the
original TMc-Nrg1 mutant mice (Karl et al., 2007), both novel
TMc-Nrg1+/− and WT mice were tested twice at ages close to
2 and 6 months for basic behavioral phenotyping and clarifica-
tion of age-dependent effects. Two cohorts of mice were used.
The first cohort of mice (n = 12 each) was sequentially tested
with the novel object recognition task on post-natal days 63–65
(PND 63–65), with the fear conditioning task on PND 66–70 and
with the Morris water maze on PND 90–110. The other cohort of
mice (male = 12; female = 10) was tested with the open field task
on PND 63 and PND 189, with the hole board task on PND 65
and PND 191, the elevated plus maze task on PND 67 and PND
193, the social preference and recognition task on PND 71, the
sucrose preference task on PND 72–75 and PND 199–202, and the
prepulse inhibition task on PND 78. The details of the behavioral
tasks are briefly described in the Supplementary Materials. These
behavioral tasks have been evaluated with varying degrees of test
validities for assessing schizophrenia-relevant behavioral deficits
in mice (Brooks and Dunnett, 2009; Lai et al., 2014).
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FIGURE 1 | (A) Schematic diagram of the targeting strategy for the novel
TMc-Nrg1+/− mutant mice. Upper panel, wild type (WT) Nrg1 locus
including 13 exons, shown as black boxes. The target vector, pKOS-53 with
a LacZ/Neo cassette, was targeted to exon 9 of Nrg1 by homologous
recombination. Lower panel, primer 0932-8, primer 0932-10, and primer
Neo3a were used to distinguish WT alleles (346 bps) from mutant alleles
(258 bps). (B) Mouse-tail DNA was submitted to PCR analysis. N: negative
control. (C) The expression level of Nrg1 proteins in the brain of both WT
and Nrg1+/− mice. ∗P < 0.05 between two genotypes.
EXPERIMENT 2: EVALUATION OF DRUG-INDUCED BEHAVIORAL
ALTERATIONS IN THE NOVEL TMc-Nrg1+/− MICE
Based on three major neurotransmitter-based hypotheses of
schizophrenia (i.e., the dopamine, glutamate, and GABA
hypotheses), three related drugs were selected to investigate which
neurotransmitter system was most vulnerable to the alterations of
behavioral performance observed in our TMc-Nrg1+/− mutant
mice. Three cohorts of male and female TMc-Nrg1+/− and
WT adult (2 months of age; n = 12 each) mice were used
in this experiment. Mice from Experiments 2A–C received an
acute administration of MK-801 (an NMDA receptor antagonist,
0.25mg/kg, i.p.), methamphetamine (a potent psychostimulant,
2mg/kg, i.p.), or pentylenetetrazol (PTZ, a GABAA receptor
antagonist, 60mg/kg, s.c.). The volume of administration was
5ml/kg and the vehicle used in this study was saline (0.9%). The
subsequent behaviors of these mice in a polyvinylchloride cham-
ber (48 × 24 × 25 cm) were recorded using an EthoVision video
tracking system or ETHOM software (Shih and Mok, 2000). On
the day of the measurements, the total distances traveled (cm) by
both the male and female mice in the first cohort were recorded in
the chamber for 60min after the administration of saline (0.9%,
5ml/kg) as a baseline. Then, locomotor activity was recorded for
two 60-min periods after the injection of MK-801. For the sec-
ond cohort of male and female mice, total distances traveled (cm)
were also recorded for a 60-min baseline period following the
administration of saline and for two 60-min periods following
methamphetamine injection. The doses of MK-801 and metham-
phetamine were chosen to avoid stereotypic behaviors in the open
field as described previously (Wu et al., 2005; Van Den Buuse
et al., 2009; Chen et al., 2012, 2014). The third cohort of male
and female mice received an injection of PTZ to induce a seizure
response, and their behaviors were videotaped and recorded in
the chamber for 1 h. The dose of PTZ was chosen based on previ-
ous dose studies of C57BL/6mice (Itoh andWatanabe, 2009). The
severities of the seizure responses were scored blindly using the
following previously described scale: 0, no response; 1, hypoac-
tivity; 2, partial clonus; 3, generalized clonus; and 4, tonic-clonic
(maximal) seizure (Ferraro et al., 1999, 2010).
EXPERIMENT 3: EXAMINATION OF THE NEUROMORPHOLOGICAL AND
NEUROCHEMICAL ALTERATIONS IN THE HIPPOCAMPI OF THE NOVEL
TMc-Nrg1+/− MICE
Based on the behavioral deficits observed in Experiment 1A,
Experiment 3 concentrated on examination of the neuromor-
phological alterations of the hippocampi of mutant and WT
mice. Based on the findings regarding the drug-induced behav-
ioral alterations of the TMc-Nrg1+/− mutant mice in Experiment
2C, we further examined the expression of GABAergic mark-
ers in the hippocampi of these mutant mice. Both male and
female TMc-Nrg1+/− and WT adult (2–4 months of age) mice
were used in this experiment. Neuromorphological analyses were
first conducted to evaluate whether the haploinsufficieny of Nrg1
resulted in neuromorphological alterations of the pyramidal neu-
rons of the CA1 region of the hippocampus (Experiment 3A).
Hippocampal samples from both mutant and WT mice were
harvested after behavioral testing to examine protein expression
using Western blot (Experiment 3B).
Experiment 3A—neuromorphological analysis of hippocampal CA1
pyramidal neurons
As a follow up to the observations of hippocampal-dependent
impairments in the novel TMc-Nrg1+/− mutant mice, hip-
pocampi were examined for any neuromorphological alterations
in the mutant mice that could partially account for the behavioral
deficits. Because pyramidal neurons of the CA1 region of the hip-
pocampus are critical for the afferent and efferent connections of
the hippocampus, the C57BL6-Tg (GFPm) driven by the Thy1
promoter specific transgenic mouse line was selected and used
for analyses of the neuromorphologies of GFP (green fluorescent
Frontiers in Behavioral Neuroscience www.frontiersin.org April 2014 | Volume 8 | Article 126 | 4
Pei et al. Schizophrenia-related phenotypes in TMc-Nrg1+/− mice
protein)-labeled CA1 pyramidal neurons of the hippocampus
(Feng et al., 2000). The expression patterns of GFP-labeled pyra-
midal neurons in Thy1-C57BL6-Tg(GFPm) transgenic mouse
line was reported previously (Feng et al., 2000) and this mouse
line has been successfully used to analyze neuromorphological
alterations of pyramidal neurons in mutant mice (Lai et al.,
2006; Chen and Lai, 2011). Based on the hippocampus-dependent
behavioral deficits observed in the novel TMc-Nrg1+/−mutant
mice, additional male and female subjects generated from our
TMc-Nrg1+/− breeding pairs with C57BL6-Tg (GFPm) back-
grounds were used in this experiment. Adult mice were anes-
thetized and transcardially perfused with PBS followed by 4%
paraformaldehyde in PBS. Fixed brains were sectioned coronally
using a vibratome. A series of 150-μm coronal sections were col-
lected and mounted on slides for scanning. Confocal microscopy
stack images of GFP-labeled neurons were obtained at intervals
of 0.4μm using 20×, 40×-oil, and 63×-oil objectives from a
Leica TCS SP5 confocal microsystem (Leica, Taipei, Taiwan). The
Neurolucida software (MicroBrightField Incorporated, Williston,
VT, USA) was used to trace and reconstruct the neurons in 3
dimensions. GFP labeling was nearly exclusively restricted to the
cell bodies and dendritic trees of CA1 pyramidal neurons of both
mutant mice and their littermate controls. Using Neurolucida
software, morphometric analyses of the GFP-labeled pyramidal
neurons (between Bregma −1.46 and −2.80mm) of the TMc-
Nrg1+/− mice and WT littermate controls were performed (total
n  4 each group) to reveal the neuromorphological differences
between genotypes. The following 14 morphological variables
were chosen based on previous studies (Lai et al., 2006; Chen
and Lai, 2011): (1) soma size (cell soma sizes were obtained by
outlining cell somas and automatically calculating the pixel areas
in μm2); (2) the distance to apical bifurcation (base of the api-
cal tuft) measured from the cell body to the major branch point
of the apical dendrite; (3) the number of branches on the apical
branches; (4) the number of apical tips; (5) the total length of
the apical tuft, which was taken as the sum of the lengths of the
apical stem and the branches that formed the tuft; (6) the apical
dendritic field area (ADFA), which measures the area of the den-
dritic field of a neuron and is calculated as the area enclosed by
a polygon that joins the most distal points of the dendritic pro-
cesses (convex area); (7) the branch angles of the primary apical
dendrites (from the distal end of apical bifurcation); (8) the num-
ber of primary basal dendrites (not including apical dendrites and
axons); (9) the total length of the primary basal dendrites; (10) the
number of branches from the basal branches; (11) the number of
basal tips; (12) the total length of the basal dendrites; (13) the
basal dendritic field area (BDFA), which measures the area of the
dendritic field of a neuron and is calculated as the area enclosed
by a polygon that joins the most distal points of the dendritic
processes (convex area); and (14) Sholl analysis of basal dendritic
complexity.
Experiment 3B—examination of the expression of GABAergic
markers in the hippocampi of the novel TMc-Nrg1+/− mice
After finishing behavioral testing for cognitive functions in
Experiment 1A, some mice from Experiment 1A were randomly
selected and used to examine the expression of hippocampal
GABAergic markers in this experiment. Hippocampi from both
WT and TMc-Nrg1+/− male (n = 7 each) and female (n = 6
each) adult mice (3–4 months of age) were quickly dissected,
frozen in liquid nitrogen, and stored at −80◦C. Tissue samples
were homogenized in lysis buffer containing 25mMTris (pH 8.0),
125mM NaCl, Protease Inhibitor Cocktail tablets (Roche, Taipei,
Taiwan) and Phosphatase Inhibitor Cocktail 1 (P2850, Sigma-
Aldrich, St. Louis, MO, USA) and then centrifuged at 12,500 rpm
(14324 g) at 4◦C for 15min. The supernatant was then collected.
The protein concentrations of the supernatants were measured
with the Bradford protein assay (Bio-Rad Laboratories, Tokyo,
Japan) and spectrometry at 620 nm. The same amount of protein
was separated by 4–10% sodium dodecyl sulfate/polyacrylamide
gel electrophoresis (SDS/PAGE) and transferred onto a nitro-
cellulose membrane (Millipore, Billerica, MA, USA). Ponceau
S staining of the membrane was used to ensure successful
transfer. Subsequently, the membranes were washed in Tris-
buffered saline containing 0.1% Tween-20 (TBST) and blocked
in 5% (w/v) skim milk for 1 h at 25◦C. The membrane was
then incubated in a 5% (w/v) skim milk solution with the
appropriate primary antibody overnight at 4◦C. The blots were
probed with the following antibodies: GAD67 (1:5000,MAB5406,
Millipore), calretinin (1:2000, AB5054, Millipore), parvalbumin
(1:2000, P3088, Sigma-Aldrich), and GAPDH (1:5000, #2118,
Cell Signaling Technology, Inc., Danvers, MA, USA). Immune
complexes were visualized using the appropriate peroxidase-
conjugated secondary antibodies (Cell Signaling Technology).
Bound antibody was detected using an enhanced chemilumi-
nescence (ECL) kit (Millipore), and densitometric analysis was
performed using Image J (a Java-based image processing program
developed at the National Institutes of Health).
EXPERIMENT 4: EVALUATION OF THE EFFECT OF VALPROATE ON THE
RESCUE OF COGNITIVE DEFICITS IN THE NOVEL TMc-Nrg1+/− MALE
MICE
Valproate, a GABAergic anti-epileptic drug and a potential phar-
macoepigenetic agent, has been reported to facilitate GABAergic-
promoter demethylation, to inhibit histone deacetylase via
chromatin remodeling, and to enhance the expression of GABA-
related genes (Guidotti et al., 2009, 2011). To evaluate rescue of
the observed behavioral deficits that resulted from GABAergic
alternation in young adult (3–4 months of age) TMc-Nrg1+/−
male mice, valproate (VPA, 1.5mmol/kg, s.c.) or vehicle (0.9%
saline, 10ml/kg) was injected into male TMc-Nrg1+/−and WT
mice twice daily for 17 days (WT/saline: n = 6; WT/VPA: n = 7;
Nrg1+/−/saline: n = 8;Nrg1+/−/VPA: n = 8). Based on the find-
ings from Experiment 1A, two behavioral tasks were selected to
evaluate the drug’s efficacy in rescuing hippocampal function in
the mutant mice. The object recognition task was conducted on
day 16. Fear conditioning training was conducted on day 16, and
contextual/cued tests of fear conditioning were conducted on day
17. Prior to behavioral testing, each subject was left untreated for
at least 12 h to exclude any acute effects of daily valproate injec-
tion. The behavioral procedures were nearly identical to those
described for Experiment 1A, with the exception that the cued
fear conditioning tests were conducted 1 h, rather than 1 day,
after contextual fear conditioning to reduce the number of testing
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days. One day after last behavioral testing (on day 18), whole
hippocampi from these mice were dissected and processed for
Western blotting using GAD67 antibody as described previously
in Experiment 3B.
STATISTICAL ANALYSIS
All data are presented as the mean ± standard error of the mean
(SEM). Statistical analyses were performed using SPSS 13.0 (SPSS
Inc., Chicago, IL, USA), and the data were analyzed with One- or
Two-Way ANOVAs or two-sample Student’s t-tests, where appro-
priate. Post-hoc analyses were performed using Fisher’s LSD tests
when the F-values revealed significant differences. A priori t-tests
(with Bonferroni adjustments when needed) were conducted to
compare genotype-dependent differences and to examine spe-
cific hypotheses. P values of < 0.05 were considered statistically
significant.
RESULTS
EXPERIMENT 1: THE NOVEL TMc-Nrg1+/− MICE HAVE NORMAL BASIC
BEHAVIORAL FUNCTIONING AND IMPAIRMENTS IN HIPPOCAMPAL-
DEPENDENT COGNITIVE FUNCTIONS
Experiment 1A—examination of cognitive-related function
A total of five behavioral tasks were conducted in this experi-
ment. In the object recognition task, a Two-Way ANOVA revealed
a significant interaction of genotype and sex [F(1, 29) = 7.222,
p = 0.012] on the time spent investigating a novel object. As
depicted in Figures 2A,B, further statistical analyses reveal a
significant simple main effect of genotype for the males (p =
0.011) but not the females (p = 0.309). Because we intended
to examine the sex-specific effects of Nrg1 in mice and also
because we found a sex difference, the following data analyses
were carried out independently for each sex. During fear con-
ditioning, the freezing responses of male TMc-Nrg1+/− mice in
both contextual [t(22) = − 2.622, p = 0.016; Figure 2C] and
cued [t(22) = −2.487, p = 0.021; Figure 2E] fear conditioning
were significantly reduced compared to WT controls. In con-
trast, no significant differences due to genotype were found for
the female mice (both p > 0.05; Figures 2D,F). In the Morris
water maze, no significant differences due to genotype were
found for either the male or female mice during the learn-
ing phase (both p > 0.05) or the probe phase (both p > 0.05),
as depicted in Figures 2G,H. Regarding sensorimotor gating
functions, no genotype-dependent differences were present in
either the males (p > 0.05; Figure 2I) or the females (p > 0.05;
Figure 2J). No genotype-dependent differences were found in
their startle response and startle habituation as well. In the social
preference and social recognition tasks, no significant genotype-
dependent differences were found in either the males (p > 0.05;
Figure 2K) or the females (p > 0.05; Figure 2L).
Experiment 1B—basic behavioral phenotyping
The basic functioning of the novel TMc-Nrg1+/− mice was fur-
ther examined using a battery of behavioral tasks. As illustrated
in Table 1, relative to the WT mice, both 2-month-old male and
female TMc-Nrg1+/− mice displayed normal behavioral profiles
across a series of basic behavioral tasks that included the open
field, hole board, elevated plus maze, 2% sucrose preference, and
hot plate tasks (all ps > 0.05). Because age-dependent effects have
been previously reported for some Nrg1 mutant mice, these mice
were examined again with the same battery of behavioral tasks at
6 months of age. Again, no genotype-dependent differences were
found in either the males or females (Table 1).
EXPERIMENT 2: EVALUATION OF DRUG-INDUCED BEHAVIORAL
ALTERATIONS IN THE NOVEL TMc-Nrg1+/− MICE
Three cohorts of male and female TMc-Nrg1+/− and WT
adult mice were used to evaluate MK-801-, methamphetamine-,
and PTZ-induced behavioral alterations in Experiments 2A–C,
respectively. In Experiment 2A, a significant MK-801 treatment
effect was found in both males [F(2, 44) = 15.505, p < 0.001]
and females [F(2, 44) = 5.188, p = 0.009]. But no significant
genotype-dependent differences were found in either the 60-
min baseline activity or MK-801-induced hyperlocomotion in
either the male (Figure 3A) or female mice (Figure 3B). Similarly,
in Experiment 2B, a significant methamphetamine treatment
effect was found in both males [F(2, 44) = 59.680, p < 0.001]
and females [F(2, 44) = 126.353, p < 0.001]. But no significant
genotype-dependent differences were found in either the 60-min
baseline activity ormethamphetamine-induced hyperlocomotion
in either the male (Figure 3C) or female mice (Figure 3D). In
contrast to the results of Experiments 2A and 2B, the severi-
ties of PTZ-induced seizures were significantly greater in male
TMc-Nrg1+/− mice [t(22) = −2.288, p = 0.032; Figure 3E] but
not in female TMc-Nrg1+/− mutant mice compared their respec-
tive WT controls. This genotype-dependent deficit of the males is
further illustrated in Figure 3F, which shows the distributions of
PTZ-induced seizure scores (Figure 3F).
EXPERIMENT 3: EXAMINATION OF NEUROMORPHOLOGICAL AND
NEUROCHEMICAL ALTERATIONS IN THE HIPPOCAMPI OF THE
NOVEL TMc-Nrg1+/− MICE
Experiment 3A—neuromorphological analysis
Based on the cognitive deficits observed in Experiment 1A, the
neuronal architectures of the GFP-labeled CA1 pyramidal neu-
rons in the hippocampus were examined. The neuromorphologi-
cal results are summarized in Table 2. Neither the male nor the
female mice exhibited any significant genotype-dependent dif-
ferences in GFP-labeled pyramidal neurons in the CA1 region
of hippocampus in any of the morphological variables that we
examined.
Experiment 3B—examination of the expression of GABAergic
markers in the hippocampus
The protein expression levels of GAD67, parvalbumin (PV),
and calretinin were examined in the hippocampi of both male
and female mice. Representative images of protein expres-
sions are shown in Figures 4A,B. Compared to WT controls,
a significant reduction of GAD67 expression was found in
our TMc-Nrg1+/−males [t(12) = 2.245, p = 0.044; Figure 4C]
but not in females (Figure 4D). Regarding calretinin, no
genotype-dependent differences were found in either males or
females (Figures 4E,F). Regarding parvalbumin, TMc-Nrg1+/−
males displayed a significant reduction of parvalbumin expression
[t(10) = 2.253, p = 0.048; Figure 4G] compared to WT controls,
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FIGURE 2 | The cognitive functions (mean + s.e.m.) of both male
and female TMc-Nrg1+/− mutant mice (black bars) and their
wild-type littermate controls (WT, white bars) were evaluated in the
Experiment 1 of this study. (A,B) In the object recognition task, a
reduction in investigation time (s) of the novel object was observed in
male, but not female, TMc-Nrg1+/− mice. (C,D) In the contextual fear
conditioning task, a reduction in freezing time percentage was observed
in male, but not female, TMc-Nrg1+/− mice. (E,F) In the cued fear
conditioning task, a reduction in freezing time percentage (%) was
found in male, but not female, TMc-Nrg1+/− mice. In contrast, no
significant genotype-dependent differences were found in the Morris
water maze, prepulse inhibition task, or the social task in either males
(G,I,K) or females (H,J,L), respectively. Dash lines indicate chance level.
∗P < 0.05 between two genotypes.
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whereas the females did not exhibit this reduction (Figure 4H).
The sex-specific reductions of hippocampal GAD67 and parval-
bumin expression found in the TMc-Nrg1+/− males of this exper-
iment might be responsible for the observed cognitive deficits of
these mice.
EXPERIMENT 4: EVALUATION OF THE EFFECT OF VALPROATE ON THE
RESCUE OF COGNITIVE DEFICITS IN THE NOVEL TMc-Nrg1+/− MALE
MICE
Based on the findings of Experiments 1A, 2, and 3B, chronic
administration of valproate was used to evaluate the effects of val-
proate on the rescue of the cognitive deficits that were observed
in the male TMc-Nrg1+/− mice. As reported in Experiment
1A, significant genotype-dependent reductions in behavioral per-
formance on the object recognition task [t(12) = 2.351, p =
0.037; Figure 5A], the contextual fear conditioning task [t(12) =
2.556, p = 0.025; Figure 5B], and the cued fear conditioning
task [t(12) = 2.469, p = 0.029; Figure 5C] were found in the
male TMc-Nrg1+/−mice that received chronic saline injections.
In contrast, after chronic injections of valproate, male TMc-
Nrg1+/−mice did not display any significant deficits in these tasks
compared to WT control males (all p > 0.05; Figures 5A–C).
For the expression of GAD67 in the hippocampus, a significant
genotype-dependent reduction (∼26%) of GAD67 was found in
mice that received chronic saline treatment [t(10) = 2.651; p =
0.024; Figure 5D]. In contrast, no significant reduction was found
in the TMc-Nrg1+/− male mice that received chronic valproate
injections compared to their WT controls.
DISCUSSION
The use of genetically modified mice that carry a truncated TMc
domain-Nrg1 gene as an experimental tool offers an alterna-
tive model with which to mimic a NRG1 deficiency in some
schizophrenic patients and to test a NRG1 loss-of-function
hypothesis for schizophrenia. In complementary to the origi-
nal TMc-Nrg1mutant strain and othermutant strains, the impact
of TMc exon ablation can be studied in both sexes using this novel
TMc-Nrg1+/− mouse strain and its functional consequences can
be compared with findings in other Nrg1-related mouse strains.
A significant reduction of Nrg1 proteins was also confirmed in
the brain of this novel mutant strain. This novel TMc-Nrg1+/−
mouse strain provides a feasible model for the characterization
of the roles of the TMc domain of Nrg1 in basic behaviors and
cognitive functions. In Experiment 1, we found that both male
and female TMc-Nrg1+/− mice displayed normal profiles of basic
behaviors but were impaired in cognition-related functions. In
Experiment 2, we found that, compared toWT controls, the injec-
tion of PTZ induced significant behavioral alterations in male
(but not female) TMc-Nrg1+/−mice, whereas the other two drugs
we tested had no effect. In Experiment 3, neuromorphological
analyses failed to reveal any Nrg1 genotype-dependent effects on
the neuronal architecture of the GFP-labeled CA1 pyramidal neu-
rons in the hippocampi of either male or female mice. However,
reductions of GAD67 and parvalbumin expression were found in
the hippocampi of male TMc-Nrg1+/− mice, and females did not
exhibit these reductions. In Experiment 4, the chronic adminis-
tration of valproate successfully rescued the observed cognitive
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FIGURE 3 | Drug-induced behavioral alterations (mean + s.e.m.) in the
novel TMc-Nrg1+/− mice (black bars) and their wild-type controls (WT,
white bars) (n = 12 each group) of this study. (A,B) Total travel distances
for the two groups of male and female mice during the 1-h saline baseline
and the 1st and 2nd 1-h periods after the injection of MK-801 (0.25mg/kg,
i.p.). (C,D) Total travel distances (mean + s.e.m.) for the two groups of male
and female mice during the 1-h saline baseline and during the 1st and 2nd 1-h
periods after the injection of methamphetamine (MA, 2mg/kg i.p.). (E) PTZ
(60mg/kg, s.c.)-induced seizure severity scores [from 0 (no response) to 4
(maximal seizure)] for both male and female mice. (F) Distributions of
PTZ-induced seizure severity scores for male mice (%). ∗P < 0.05 between
two genotypes.
deficits of male TMc-Nrg1+/− mice and hippocampal GAD67
expression.
To the best of our knowledge, this study is the first to charac-
terize behavioral phenotypes of this novel TMc-Nrg1+/− mutant
strain. We also illustrated and verified that the truncated region
had a hydrophobic protein structure that was located in the TMc
of Nrg1. In complementary to those existing Nrg1-related mutant
mouse strains, this novel mouse strain used in this study can be
referred as a novel TMc-Nrg1 mutant strain. Our behavioral phe-
notyping data indicated that the truncation of the TMc domain
in our TMc-Nrg1 mutant mice affected some cognitive func-
tions but apparently did not have any effect on basic behaviors.
The basic behavioral data reported in the present study, along
with data regarding the basic behavioral phenotypes that have
been reported for different lines of Nrg1-related mutant mice, are
summarized in Table 3. There are several inconsistencies in this
dataset; for example, PPI deficits have been observed in studies of
type III Nrg1mutant mice (Chen et al., 2008), ErbB4mutant mice
(Shamir et al., 2012), ErbB2/4 mutant mice (Barros et al., 2009),
and NRG1-overexpressing transgenic mice (Deakin et al., 2009;
Kato et al., 2010), and in some (but not all) studies of the orig-
inal TMc-Nrg1 mutant mice (Stefansson et al., 2002; Desbonnet
et al., 2012). These original TMc-Nrg1+/− mutantmice have been
widely used in recent years. It is of great interest to compare the
behavioral phenotypes of these original TMc-Nrg1 mutant mice
with those of our novel TMc-Nrg1 mutant mice. As indicated in
Table 3, the behavioral phenotypes of the original TMc-Nrg1+/−
mutant mice seem to vary somewhat across studies. Generally,
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Table 2 | Neuromorphological analyses (mean ± s.e.m.) of GFP-labeled pyramidal neurons in the hippocampi of male and female TMc-Nrg1+/−
(Nrg1+/−) mice and their wild-type (WT) littermate controls.
Male Female
WT Nrg1+/− WT Nrg1+/−
Soma size (μm2) 92.090±4.974 86.850±5.725 86.270± 4.278 80.190± 6.040
Distance to apical bifurcation (μm) 241.100±55.430 265.200±66.730 257.100± 57.750 249.200± 65.130
Number of branches of apical branches 19.000±2.781 18.170±1.249 19.880± 2.356 19.500± 1.268
Number of apical tips 20.000±2.781 18.830±1.138 20.630± 2.412 20.380± 1.322
Total length of the apical tuft (μm) 3009.000±397.700 2621.000±465.900 2973.000± 370.100 2593.000± 348.000
Apical dendritic field area (ADFA) (× 1000μm2) 11.100±1.644 9.512±2.588 10.850± 1.493 9.532± 1.980
Branch angle of primary apical dendrites (◦) 49.270±4.899 68.800±13.010 69.650± 11.360 48.420± 7.560
Number of primary basal dendrites 3.444±0.242 3.900±0.315 3.286± 0.360 3.400± 0.221
The total length of primary basal dendrites (μm) 79.310±16.820 87.610±13.460 95.000± 30.090 69.120± 13.810
Number of branches of basal branches 20.110±1.989 19.400±0.957 22.430± 1.757 21.900± 1.980
Number of basal tips 22.780±1.722 23.000±1.000 25.000± 1.464 24.900± 1.894
The total length of basal dendrites (μm) 3301.000±293.600 3001.000±294.600 3590.000± 317.500 3179.000± 429.300
Basal dendritic field area (BDFA) (× 1000μm2) 10.230±1.309 8.047±1.077 10.690± 1.284 10.720± 1.893
Sholl analysis of basal dendritic complexity
Distance to soma (μm) 10 0.444±0.342 1.900±0.795 0.429± 0.578 1.300± 0.297
20 4.222±0.946 4.800±0.712 3.571± 0.563 4.500± 0.429
30 5.333±1.108 7.100±1.016 5.429± 0.674 7.100± 0.841
40 7.333±1.308 9.900±1.394 10.140± 0.702 9.600± 0.829
50 10.110±0.955 12.400±1.376 12.290± 0.605 11.900± 0.680
60 12.000±1.065 13.200±1.083 13.570± 0.359 13.200± 0.841
70 13.110±0.872 14.500±0.860 15.860± 0.716 14.300± 0.857
80 14.110±1.138 15.800±0.554 17.000± 1.024 14.600± 0.951
90 15.000±1.065 16.400±0.806 16.570± 1.016 15.100± 0.896
100 14.780±1.265 15.800±0.827 16.570± 1.083 15.200± 1.088
>100 9.127±0.632 8.756±0.725 9.108± 1.076 8.335± 0.509
this line of mutant mice has been reported to exhibit behavioral
deficits in some behavioral tasks, such as the PPI, social recog-
nition, and open field tasks (Stefansson et al., 2002; O’Tuathaigh
et al., 2006, 2007; Boucher et al., 2007; Karl et al., 2007; Van Den
Buuse et al., 2009; Chesworth et al., 2012; Desbonnet et al., 2012).
However, our novel TMc-Nrg1+/− mutant mice did not exhibit
any significant impairment in these behavioral tasks. We also
found no age-dependent effects in our novel TMc-Nrg1 mutant
mice after examination at 2 and 6 months of age; this result is
similar to reports that the age of onset is not associated with
the NRG1 genotype in patients with schizophrenia (Kampman
et al., 2004; Voineskos et al., 2009). In contrast, Karl et al. reported
that the original TMc-Nrg1+/− mutant mice do not display age-
dependent hyperlocomotion until the age of 4.5 months (Karl
et al., 2007), but these mice have been found to exhibit hyper-
locomotion at 3 month of age in other studies (Van Den Buuse
et al., 2009). Different targeting strategies were used to gener-
ate our new TMc-Nrg1 mutant mice and the original TMc-Nrg1
mutant mice. But as we described previously, it is possible that
both TMc-Nrg1mutantmouse strains are targeting the same TMc
exon due to differences in exon annotation. To further verify this
possibility, we conducted a nucleotide BLAST search using our
primer set and the forward primer sequence reported previously
(Liu et al., 1998a; Lai et al., 2010). Based on the location of the
forward primer and the size of PCR product, we found that the
forward primer used for the original TMc-Nrg1 mutant mice
located ∼951 bps upstream of the forward primer used for our
new TMc-Nrg1 mutant mice, suggesting both TMc-Nrg1 mutant
mouse strains are targeting the same exon. However, it should
be noted that different targeting strategies can result in different
biological functions. As far as we can tell from previous litera-
tures (Liu et al., 1998a; Lai et al., 2010), the original TMc-Nrg1
mutant strain was designed to generate most soluble forms of
Nrg1 by replacing the TMc exon with a mini-exon that intro-
duces stop codons right upstream of the TMc. In contrast, our
new TMc-Nrg1mutant mice have no such added stop codons and
are more likely to result in complete functional knockout of all
Nrg1 isoforms except for those that naturally terminate before the
TMc (such as SMDF). In addition to biological difference, above-
mentioned discrepancy could be due to different experimental
designs, different experimental procedures (Van Den Buuse et al.,
2009; Karl et al., 2011), age differences, or genetic background
differences. As indicated in Table 3, differences in gene targeting
strategy and the truncation of different domains or exon loca-
tion in Nrg1 gene appear to have differential effects on behavioral
performance.
A sex-specific effect of Nrg1 on cognitive function was found
in Experiment 1 of this study. Our male TMc-Nrg1+/− mutant
mice exhibited behavioral deficits in the novel object recog-
nition task, contextual fear conditioning task, and cued fear
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FIGURE 4 | The neurochemical analysis of the expression of GABAergic
markers in the hippocampi of the novel TMc-Nrg1+/−mutant mice
(black bars) and their wild-type controls (WT, white bars) determined
by Western blot. (A,B) Representative Western blots of hippocampal
tissue (30μg/lane) with GAD67 (67 kDa), calretinin (29 kDa), parvalbumin
(12 kDa), and GAPDH (37 kDa) from males and females. (C–H)
Quantification of the data revealed reductions in GAD67 and parvalbumin
expression levels in the hippocampi of male (C,E,G), but not female
(D,F,H), TMc-Nrg1+/−mice. Data are presented as the mean + s.e.m.
∗P < 0.05 between two genotypes.
conditioning task, whereas females did not display these impair-
ments. As indicated in Table 3, many Nrg1-related studies have
only been conducted on male mice. Interestingly, either haploin-
sufficiency of Nrg1 or overexpression of Nrg1 (Deakin et al.,
2009, 2012; Kato et al., 2010) in mice can result in some types
of cognitive deficits, which implies a possible U-shaped relation-
ship between Nrg1 expression and cognitive function, which has
been reported for the COMT gene (Honea et al., 2009). Few stud-
ies have examined female mice, and these studies have reported
that the original TMc-Nrg1+/− mutant female mice exhibit
hyperlocomotion, altered social recognition, and impaired con-
textual and cued fear conditioning (O’Tuathaigh et al., 2006,
2007; Chesworth et al., 2012). In contrast, both male and female
TMc-Nrg1+/− mutants and their WT littermates were exam-
ined in this study. The basic and cognitive functions of our
novel TMc-Nrg1+/− mutant female mice seemed to be largely
unaffected when compared to their female WT controls. The
sex-specific alterations of cognitive function observed in our
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FIGURE 5 | The effect of chronic valproate treatment on the rescue of
cognitive deficits in male wild-type (WT, white bars) and TMc-Nrg1+/−
mutant (black bars) mice. Three cognitive tasks, including (A) an object
recognition task, (B) a contextual fear conditioning task, and (C) a cued fear
conditioning task, were conducted. Either valproate (1.5mmol/kg, s.c.) or 0.9%
saline was injected twice a day for 17 days. The object recognition task was
conducted on day 16,and the contextual/cued tests of fear conditioning were
performed on day 17. (D) The expression of GAD67 in the hippocampus of both
WT and TMc-Nrg1+/− mice after chronic injections of either saline or valproate.
Data are presented as the mean + s.e.m. ∗P < 0.05 between two genotypes.
male TMc-Nrg1+/−mutant mice are somewhat consistent with
the gender-specific differences in patients with schizophrenia
(Kulkarni et al., 2012). This finding also suggests a potential inter-
action between NRG1/ErbB signaling and sex hormones (e.g.,
estrogen) in the regulation of schizophrenia-related cognitive
deficits; a similar interaction has been described in human stud-
ies (Wong and Weickert, 2009; Agim et al., 2013). Examination
of the protective effects of estrogen (i.e., the estrogen protection
hypothesis of schizophrenia) in our TMc-Nrg1 mutant mice is
warranted.
In Experiment 2, based upon major neurotransmitter-based
hypothesis of schizophrenia, 3 related drugs were chosen to
evaluate drug-induced behavioral alterations in our novel TMc-
Nrg1+/−mutant mice. Our behavioral data revealed a sex-specific
effect of PTZ (but not MK-801 or methamphetamine) on PTZ-
induced responses in male TMc-Nrg1+/−mutant mice. It has
been reported that Nrg1 interacts with NMDA receptors through
Fyn kinase and Pyk2 (proline-rich tyrosine kinase 2) and that
attenuated Nrg1 signaling affects the phosphorylation of NR2B
receptors in Nrg1+/−mutant mice with either TMc-domain
truncation or EGF-like domain truncation (Bjarnadottir et al.,
2007). Moreover, subchronic injections of MK-801 (0.2mg/kg,
s.c.) disrupt sociability and social novelty preference in the
original TMc-Nrg1+/−mutant mice (O’Tuathaigh et al., 2010).
However, compared with WT controls, different doses of MK-
801 (0.01, 0.05, 0.25mg/kg, i.p.) did not affect MK-801-induced
hyperlocomotion in the original TMc-Nrg1+/− mutant mice
(Van Den Buuse et al., 2009), which is consistent with our cur-
rent findings in the new TMc-Nrg1+/−mutantmice. Additionally,
no significant differences were found in [3H]MK-801 and
[3H]kainate binding levels with Nrg1 status in the brains of the
original TMc-Nrg1+/− mutant mice using in situ radioligand
binding (Dean et al., 2008). Glutamate and GABA concentrations
in the brains of these original TMc-Nrg1+/− mutant mice also
did not differ from those of WT mice (O’Tuathaigh et al., 2010).
In contrast, alteration of GABAergic neurons is considered as one
of the most reliable abnormalities found in post-mortem analyses
of the schizophrenic brain (Lewis et al., 2005). Accumulating evi-
dence emerging from human genetic studies suggests the involve-
ment of GABA-A receptor subunit genes in schizophrenia (Lewis
et al., 2003) and the genetic link between GAD67 and early-onset
schizophrenia (Addington et al., 2005). Dysfunction of cerebral
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cortex (especially PFC) and hippocampus in schizophrenia is also
thought to include alteration in GABAergic, inhibitory neuro-
transmission (Guidotti et al., 2005; Lewis et al., 2005). Although
PTZ is usually considered as a convulsant drug and has less face
validity to schizophrenia compared to MK-801 and metham-
phetamine, the well-established PTZ-induced responses appear
to be a useful index for evaluating the vulnerability of GABAergic
system inmutantmice with reasonable construct validity and pre-
dictive validity. Our data suggest that the GABA transmission of
our male TMc-Nrg1+/− mutant mice was affected to a greater
extent than glutamatergic and dopaminergic transmission. The
truncation of different loci of Nrg1 might have differential effects
compared to other Nrg1-related mutant mice.
Furthermore, because both Nrg1 and ErbB4 are highly abun-
dant in the hippocampus (Corfas et al., 1995; Law et al., 2004;
Vullhorst et al., 2009) and also because some hippocampus-
dependent cognitive deficits were observed in Experiment 1,
we examined GFP-labeled CA1 pyramidal neurons to eluci-
date any neuromorphological alterations of excitatory neurons
in the hippocampus. This study might be the first to analyze
morphometric alterations of CA1 pyramidal neurons in TMc-
related Nrg1+/− mutant mice. However, no significant genotype-
dependent neuromorphological alterations were found in either
the males or females in any of the morphological variables we
examined, suggesting that the neuromorphology and function
of these hippocampal excitatory units may be intact in our
TMc-Nrg1+/−mutant mice. Our current results suggest that the
GABAergic system is affected to a greater extent than either
the glutamatergic or dopaminergic systems in the brains of our
mutant mice, especially the males. It has been proposed that
NRG1 has both forward and reverse functions in ErbB/NRG1
signaling. The forward signaling via ErbBs promotes the forma-
tion of the excitatory and inhibitory synapses of interneurons.
The reverse signaling is ErbBs-independent; Nrg1 is cleaved by
gamma-secretase to release the intracellular domain (NRG1-
ICD), which is important for the development of cortical pyrami-
dal neurons (Chen et al., 2008, 2010; Fazzari et al., 2010; Pedrique
and Fazzari, 2010). Although more work needs to be performed
to elucidate the role of NRG1-ICD in the hippocampus, our cur-
rent data suggest that the deficiency of TMc domain might have a
minor impact on reverse signaling that alters the neuromorphol-
ogy of CA1 pyramidal neurons, whereas this haploinsufficiency
might have a major impact on the development and neuroplas-
ticity of interneuron that is mediated through forward signaling;
these suppositions are also supported by the PTZ-induced behav-
ioral alterations we observed in our TMc-Nrg1+/− mutant mice.
Additionally, further evidence arose from Experiment 3B, in
which we found sex-specific reductions on GAD67 and par-
valbumin expression in the hippocampi of our TMc-Nrg1+/−
mutant mice. Indeed, it has been reported that Nrg1 and ErbB4
signaling controls the development of inhibitory circuitries in
the mammalian cerebral cortex through GABAergic interneu-
rons (Barros et al., 2009; Vullhorst et al., 2009; Pedrique and
Fazzari, 2010; Wen et al., 2010; Cahill et al., 2012) and that Nrg1
treatment has a synaptogenic effect, which is possibly mediated by
the stabilization of PSD-95 on GABAergic interneurons, but not
glutamatergic neurons (Ting et al., 2011). A genetic association
between ErbB4 and human cortical GABA levels has also been
reported (Marenco et al., 2011). Besides, exogenous NRG1 down-
regulated the expression of GABAA receptors in hippocampal
CA1 pyramidal neurons (Okada and Corfas, 2004). Our find-
ings from Experiment 3B are concordant with these findings and
indicate the importance of Nrg1 in the regulation of GAD67 and
parvalbumin expression in the hippocampus. Thus, haploinsuffi-
ciency of Nrg1 resulted in reductions in hippocampal GAD67 and
parvalbumin expression, which may have caused alterations in
the inhibitory interneuron networks by desynchronizing gamma
oscillations [as has been proposed previously (Gonzalez-Burgos
and Lewis, 2008; Del Pino et al., 2013)] and caused the cogni-
tive impairments we observed in male Nrg1 mutant mice. This
mechanismmay contribute to the pathogenesis of some cognitive
deficits in some patients with schizophrenia andNrg1 alterations.
The effect of valproate on the rescue of the cognitive deficits
observed in our male TMc-Nrg1 mutant mice should be of
great interest to researchers. Valproate is a pharmacoepige-
nomic agent that has epigenetic effects on the modification
of GABAergic interneurons (Csoka and Szyf, 2009). Valproate
has been reported to ameliorate cognitive impairments in adult
mice via demethylation of GABAergic-promotors (Tremolizzo
et al., 2002, 2005; Matrisciano et al., 2013), inhibition of his-
tone deacetylases (Phiel et al., 2001), and enhancement of central
GABAergic tone that is mediated through an inhibition of GABA-
transaminase (Johannessen, 2000). The reciprocal interaction
between defects of NRG1 and hypermethylation of GABAergic
promotors remains unclear. Our findings indicate that deficien-
cies of Nrg1 resulted in reductions of hippocampal GAD67
and parvalbumin expression, which might affect hippocampus-
related cognitive functions. Interestingly, protracted treatment
with valproate ameliorated observed cognitive deficits and the
reduction of hippocampal GAD67 expression in our male TMc-
Nrg1 mutant mice. It has also been reported that protracted
valproate treatment increased GAD67 mRNA expression in
the brain, which likely facilitated GABAergic neurotransmission
(Loscher, 1999; Tremolizzo et al., 2002, 2005). Notably, in terms
of the pharmacokinetics of valproate, the dose we used has been
shown to be comparable to the effective concentrations (0.15–
0.30mmol/kg) of valproate that are administered to psychiatric
patients (Tremolizzo et al., 2005). Accordingly, the observed cog-
nitive deficits that resulted from the haploinsufficiency of Nrg1
and the reduction of GABAergic transmission in our male TMc-
Nrg1 mutant mice were likely to be ameliorated by the upregula-
tion of the GABAergic system due to chronic valproate injections.
It is of interest to confirm hippocampal GAD67 and parvalbu-
min expressions in a new batch of valproate-treated Nrg1 mutant
mice that did not receive any behavioral testing and further exam-
ine its epigenetic effect. Although the underlying mechanisms
require further investigation, our data suggest that valproate has
great potential for improving cognitive deficits in patients with
schizophrenia, especially males with NRG1 haploinsufficiency.
Further studies are greatly needed.
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